Improved oral absorption of carbamazepine from 1-O-alkylglycerol stabilized o/w nanoemulsions

Current Nanoscience

Volumn 3, Issue 4, 2007, Pages 339-344

  Madhusudhan, B ^a,b   Rambhau, D ^a,c   Apte, S S ^a,c   Gopinath, D ^a,d  

^a KAKATIYA UNIVERSITY   (India)

^b DR REDDY'S LABORATORIES LTD   (India)

^c NATCO   (India)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

1 O alkylglycerol; Carbamazepine; Lecithin; Nanoemulsions; Oral absorption

Indexed keywords

ABSORPTION; BLOOD; MECHANICAL PERMEABILITY;

CARBAMAZEPINE; LECITHIN; NANOEMULSIONS; ORAL ABSORPTION;

MICROEMULSIONS;

CARBAMAZEPINE; GLYCEROL DERIVATIVE; NANOPARTICLE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; AREA UNDER THE CURVE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUTION; DRUG STABILITY; EMULSION; GASTROINTESTINAL ABSORPTION; IN VIVO STUDY; INTESTINE; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; REVIEW;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 36349019307     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341307782418586     Document Type: Review

References (23)

1. Takino, T.; Konishi, K.; Takakura, Y.; Hashida, M. Biol. Pharm. Bull., 1994, 17, 121.
2. Porter, C.J.; Kaukonen, A.M.; Boyd, B.J.; Edwards, G.A.; Charman, W.N. Pharm Res., 2004, 21, 1405.
3. Myers, R.A.; Stella, V.J. Int. J. Pharm., 1992, 78, 217.
4. De Smidt, P.C.; Campanero, M.A.; Troconiz, I.F. Int. J. Pharm., 2004, 270, 109.
5. Kimura, T.; Fukui, E.; Kageyu, A.; Kurohara, Y.; Nakayama, T.; Morita, Y.; Shibusawa, K.; Ohsawa, S.; Takeda, Y. Chem. Pharm. Bull., 1989, 37, 439.
6. Tarr, B.D., Yalkowsky, S.H. Pharm. Res., 1989, 6, 40.
7. Buszello, K.; Muller, B.W. In Pharmaceutical Emulsions and Suspensions; Nielloud, F.;Marti-Mestres, G. Ed.; Marcel Dekker, Inc., New York, 2000; pp. 191-228.
8. Nicolaos, G.; Crauste-Manciet, S.; Farinotti, R.; Brossard, D. Int. J. Pharm., 2003, 263, 165.
9. Ilan, E.; Amselem, S.; Weisspapir, M.; Schwarz, J.; Yogev, A.; Zawoznik, E.; Friedman, D. Pharm. Res., 1996, 13, 1083.
10. Gershanik, T.; Benita, S. Pharm. Dev. Technol., 1996, 1, 147.
11. Paltauf, F. In Ether Lipids: Biochemical and Biomedical Aspects, Mangold, H.K.; Paltauf, F. Ed.; Academic press, New York, 1983; pp. 309-353.
12. Erdlenbruch, B.; Jendrossed, V.; Eibl, H.; Lakomek, M. Exp. Brain Res., 2000, 135, 417.
13. Reynolds, J.E.F. Martindale, The Extra Pharmacopoeia, 31st Edn, The Pharmaceutical press, London, 1996.
14. Riad, L.E.; Chan, K.K.; Wagner, W.E.; Sawchuk, R.J. J. Pharm. Sci., 1986, 75, 897.
15. Maas, B.; Garnett, W.R.; Pellock, J.M.; Comsock, T.J. Ther. Drug monitoring., 1987, 9, 28.
16. Meyer, M.C.; Straughn, A.B.; Jarvi, E.J.; Wood, G.C.; Pelsor, F.R.; Shah, V.P. Pharm. Res., 1992, 9, 1612.
17. Baumann, W.J.; Mangold, H.K. J. Org. Chem., 1964, 29, 3055.
18. Benita, S.; Levy, M.L. J. Pharm. Sci., 1993, 82, 1069.
19. Doluisio, J.T.; Billups, N.F.; Dittert, L.W.; Sugita, E.T.; Swintosky, J.V. J. Pharm. Sci., 1968, 58, 1196.
20. Toguchi, H.; Ogawa, Y.; Iga, K.; Yashiki, T.; Shimamoto, T. Chem. Pharm. Bull., 1990, 38, 2796.
21. Embleton, J.K.; Pouton, C.W. Adv. Drug Del. Rev., 1997, 25, 15.
22. Mac Gregor, K.J.; Embleton, J.K.; Lacy, J.E.; Perry, E.A.; Solomon, L.J.; Seager, H.; Pouton, C.W. Adv. Drug Deliv., 1997, 25, 33.
23. Armand, M.; Pasquier, B.; Andre, M.; Borel, P.; Senft, M.; Peyrot, J.; Salducoi, J.; Portugal, H.; Jaussan, V.; Lairon, D. Am. J. Clin. Nutr., 1999, 70, 1096.